1. Home
  2. TAOP vs CMND Comparison

TAOP vs CMND Comparison

Compare TAOP & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TAOP

Taoping Inc.

HOLD

Current Price

$1.33

Market Cap

2.9M

Sector

Technology

ML Signal

HOLD

Logo Clearmind Medicine Inc.

CMND

Clearmind Medicine Inc.

BUY

Current Price

$1.86

Market Cap

2.9M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
TAOP
CMND
Founded
1993
2017
Country
China
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9M
2.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TAOP
CMND
Price
$1.33
$1.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
75.8K
256.0K
Earning Date
12-08-2025
01-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$36,196,786.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.19
$1.74
52 Week High
$20.10
$70.00

Technical Indicators

Market Signals
Indicator
TAOP
CMND
Relative Strength Index (RSI) 28.93 57.43
Support Level $1.19 $2.40
Resistance Level $1.50 $2.88
Average True Range (ATR) 0.14 0.25
MACD -0.06 -0.02
Stochastic Oscillator 14.41 54.15

Price Performance

Historical Comparison
TAOP
CMND

About TAOP Taoping Inc.

Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.

About CMND Clearmind Medicine Inc.

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Share on Social Networks: